Sampre Nutritions’ Subsidiary to Establish Manufacturing Facility in Egypt

Sampre Nutrition Holding Limited, a subsidiary of the BSE-listed Sampre Nutritions Limited, has taken a significant step toward international expansion by entering into a land purchase agreement with Orascom Industrial Parks in Egypt. Executed in February 2026, the deal secures a 30,000-square-meter industrial land parcel dedicated to food processing and confectionery manufacturing. This move is designed to bolster the company’s manufacturing capacity and facilitate long-term growth within high-growth international markets.

The company's financial performance reflects a period of aggressive growth and robust profitability. For the first half of the 2026 fiscal year, Sampre reported a 77 per cent increase in revenue to Rs 20.86 crore, while net profit surged more than six-fold to Rs 160.41 lakh compared to the previous year. This trajectory was mirrored in the second quarter, where revenue hit Rs 9.99 crore and net profits grew by 620 per cent year-on-year, underscoring the company’s improving operational efficiency and market demand.

To support this expansion, Sampre has focused on strategic capital restructuring and fundraising. The Board recently approved a 1:1 bonus issue of over 43 million equity shares and the conversion of 13 Foreign Currency Convertible Bonds (FCCBs) into equity. Furthermore, promoters Mr. Brahma Gurbani and Ms. Meera Gurbani converted existing unsecured loans of Rs 7.43 crore into 1.77 million equity shares at Rs 42 per share. These actions, alongside a substantial USD 40 million FCCB issue intended for the Egypt and Liberia markets, provide the necessary capital for broadening the company's global footprint.

Operational growth is being fuelled by high-profile manufacturing agreements with major industry players. A notable three-year partnership with Reliance Consumer Products Limited (RCPL) is expected to generate between Rs 12 to 15 crores in annual revenue through the supply of confectionery and nutraceutical products. Additionally, Sampre has secured a three-year contract with Tolaram Wellness Ltd. in Nigeria, projected at Rs 30 crore, and a separate agreement with Rama Exports worth Rs 15 crore, cementing its position as a preferred manufacturing partner.

Recognised for its excellence with the India 5000 Best MSME Award 2024, Sampre Nutritions is successfully transitioning from a domestic player to an international manufacturer. By combining strong domestic partnerships with the new manufacturing hub in Egypt, the company is positioning itself to capture emerging opportunities in the global FMCG sector. The integration of increased capacity and diversified revenue streams marks a transformative phase in the company's corporate history.

Disclaimer: The article is for informational purposes only and not investment advice.